Femilon (0.02+0.15) Mg (Estradiol)
Price range: $49.06 through $99.17Required
| Pack Size | Price | Unit Price | Quantity | |
|---|---|---|---|---|
| 21 Tablet/s | $49.06 | $2.34 / tablet | ||
| 42 Tablet/s | $66.70 | $1.59 / tablet | ||
| 84 Tablet/s | $99.17 | $1.18 / tablet |
About Femilon (0.02+0.15) Mg (Estradiol)
Medicine information
- Active ingredient
- Desogestrel + Ethinylestradiol
- Indication
- Oral contraception for prevention of pregnancy
- Manufacturer
- Organon (India) Pvt. Ltd.; marketed by Abbott India Limited
- Packaging
- Strip of 21 tablets
- Strength
- 0.15+0.02 mg
- Dosage form
- Uncoated tablet
- Route
- Oral
Medicine overview
Femilon is a combined oral contraceptive containing desogestrel 0.15 mg, a progestin, and ethinylestradiol 0.02 mg, an estrogen. Despite the product description supplied as “Estradiol,” the verified active estrogen in Femilon is ethinylestradiol. It is an oral hormonal contraceptive used to prevent pregnancy. The two hormones mainly prevent ovulation and also produce changes in cervical mucus and the uterine lining that contribute to contraceptive activity.
What it is used for
Femilon is used primarily to prevent pregnancy in women who choose a combined oral contraceptive. Combined oral contraceptives can also make menstrual bleeding more regular and may reduce menstrual blood loss and painful periods in some users. These additional effects should not be treated as a reason to use Femilon without appropriate medical assessment.
How it works
Femilon combines estrogen and progestin hormones. These hormones suppress gonadotropins, the hormonal signals involved in the menstrual cycle, with inhibition of ovulation being the main contraceptive effect. The medicine also changes cervical mucus, making sperm passage through the cervix more difficult, and alters the endometrium, or lining of the uterus. Together, these effects reduce the likelihood of pregnancy.
How it is taken
Femilon is taken by mouth. The verified Femilon pack contains 21 tablets, and combined oral contraceptive tablets should be taken consistently at the same time each day according to the prescribed pack instructions. For 21-tablet regimens, a 7-day tablet-free interval generally follows completion of the pack, with no more than seven days between packs. Starting instructions and what to do after missed tablets depend on the circumstances, so follow the Femilon pack instructions or advice from the prescriber rather than creating a replacement schedule.
Important warnings
Femilon is a combined hormonal contraceptive and can increase the risk of venous and arterial blood clots. It should not be used in women with certain thromboembolic disorders, significant cardiovascular or cerebrovascular disease, severe uncontrolled hypertension, migraine with focal neurological symptoms, severe liver disease, certain hormone-sensitive cancers, unexplained genital bleeding, or known or suspected pregnancy. Smoking substantially increases cardiovascular risk, particularly after age 35. Important interactions include medicines that can reduce contraceptive effectiveness, such as rifampin, certain antiseizure medicines and St. John’s wort. Combined hormonal contraceptives can also reduce lamotrigine concentrations. Certain hepatitis C regimens containing ombitasvir/paritaprevir/ritonavir with or without dasabuvir are contraindicated with ethinylestradiol-containing contraceptives. Seek urgent medical attention for symptoms suggesting a blood clot, stroke, heart attack, severe liver problem, or sudden vision loss.
Side effects and monitoring
Common effects associated with desogestrel/ethinylestradiol contraceptives include nausea, vomiting, abdominal cramps or bloating, breakthrough bleeding or spotting, changes in menstrual flow, breast tenderness, headache and weight changes. Less common but serious risks include deep-vein thrombosis, pulmonary embolism, stroke, myocardial infarction, significant hypertension, gallbladder disease and liver tumors. Urgent assessment is needed for unexplained leg swelling or pain, sudden chest pain or shortness of breath, sudden neurological symptoms, or unexplained loss of vision. Blood pressure and relevant cardiovascular, metabolic and other risk factors should be assessed as clinically appropriate during use.
Pregnancy
Femilon should not be used during pregnancy. If pregnancy occurs, combined oral contraceptive treatment should be discontinued because there is no contraceptive benefit during pregnancy.
Breastfeeding
Estrogen/progestin oral contraceptive hormones can pass into human milk, and estrogen-containing contraceptives may reduce the quantity or quality of breast milk. Choice and timing of contraception while breastfeeding should therefore be discussed with a healthcare professional, particularly during the postpartum period.
Food and drink
No Femilon-specific clinically important food restriction was verified. The effect of food on the bioavailability of the corresponding desogestrel 0.15 mg/ethinylestradiol 0.02 mg combination has not been established in the authoritative labeling reviewed.
Storage
Store below 30°C.
Frequently asked questions
Is Femilon an estradiol-only tablet?
No. Femilon contains two active hormones: desogestrel 0.15 mg and ethinylestradiol 0.02 mg. It is a combined oral contraceptive rather than an estradiol-only medicine.
Can Femilon change my periods or cause spotting?
Yes. Spotting, breakthrough bleeding and changes in menstrual flow can occur with combined oral contraceptives, particularly during early cycles. Persistent or unusual bleeding should be discussed with a healthcare professional.
What happens if I forget a Femilon tablet?
Missing active contraceptive tablets can reduce protection against pregnancy. The appropriate action depends on how many tablets were missed and where you are in the pack, so follow the Femilon missed-pill instructions or obtain advice from a healthcare professional.
Does Femilon protect against sexually transmitted infections?
No. Hormonal contraceptive pills prevent pregnancy but do not protect against HIV or other sexually transmitted infections.
Can smoking make Femilon more dangerous?
Yes. Smoking increases the risk of serious cardiovascular complications with combined oral contraceptives, and the risk rises with age and the amount smoked. Combined hormonal contraceptives are contraindicated for women over 35 who smoke in the authoritative labeling reviewed.
Can I use Femilon while breastfeeding?
Combined estrogen/progestin contraceptives can reduce breast-milk production, and small amounts of contraceptive hormones can enter human milk. A healthcare professional should advise on an appropriate contraceptive method and when to start it after childbirth.
Can other medicines make Femilon less effective?
Yes. Some medicines, including rifampin and certain antiseizure medicines, as well as St. John’s wort, can reduce the effectiveness of hormonal contraceptives. Tell the prescriber or pharmacist about all medicines and herbal products you use.
Does Femilon contain 0.02 mg of estradiol?
No. The verified Femilon formulation contains 0.02 mg of ethinylestradiol, a synthetic estrogen, together with 0.15 mg of desogestrel.
Sources
Medical information notice: This information does not replace advice from a qualified healthcare professional. Use prescription medicine only as directed by the prescriber and the approved product information.
| Active Ingredients | Estradiol + Desofestrel |
|---|---|
| Manufacturer | Organon Ltd |
| Packaging | Qty |
| strength | (0.02+0.15)mg |
| Delivery Time | 6 To 15 days |
Related products
Duvadilan Retards 40 Mg (Isoxsuprine Hcl)
Femalegra 100 Mg (Sildenafil)
Ferium Xt Tablet (Ferrous Ascorbate)
Folvite Active Capsule (L-Methylfolate)
Lovegra 100 Mg (Sildenafil)
Reviews
There are no reviews yet.